Posted on September 25, 2018 Workshop on Transfer of Scientific Knowledge in Duchenne Muscular Dystrophy
Posted on August 29, 2018 SOM Biotech at BIT’s 16th Annual Congress of International Drug Discovery Science and Technology 2018
Posted on July 17, 2018 SOM Biotech Announces Initiation of Phase 2a Clinical Trial of SOM3355 in Huntington’s Disease Patients